|
05/07/2010 New products monoclonal antibodies TSLP
|
|
10/3/2010
Advances in Toll-like Receptor research
Goubier, A., et al. 2008; Immunity, 29: 464-475
Plasmacytoid dendritic cells mediate oral tolerance
Flacher V., et al, J. Invest Dermatol. 2010 Mar;130(3):755-62. Epub 2009 Nov 5 -
Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis.
Barton G.M. et al., Nat Rev Immunol, 2009, 9, 535- A cell biological view of Toll-like receptor function regulation through compartmentalization.
Ewald S.E. et al., Nature Letters 2008, 456, 658- The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.
Park B. et al.,Nature Immunol, 2008, 9, 1407- Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.
Dendritics offers TLR3 antibodies- For functional receptor studies.
|
|
 .jpg)   
DENDRITICS offers a wide range of monoclonal antibodies to characterize dendritic cell phenotype and function, in the steady-state, in animal models and in human diseases such as allergy, cancer, and skin diseases.
DENDRITICS offers a specific monoclonal antibody custom-made service: you are garanteed to get several clones (10-40) for your specific program.
DENDRITICS antibodies can be used in Flow cytometry, ELISA, Immunohistology, and biochemical studies.
DENDRITICS created in 2005, leans on:
- 15 years of expertise in dendritic cells and immunology fundamental research and iacquired within the Laboratory of Immunological Research of Schering-Plough, LIR (200 publications and 40 patents).
- The exclusive license of Schering-Plough to manufacture and to sell LIR antibodies as DCGM4-Langerin, clone 120G8 for mouse pDCs depletion, DC-LAMP, DCIR, antibasophil, FDF03..
- The most of Dendritics monoclonal antibodies have been published and validated in major international journals.
DENDRITICS monoclonal antibodies do not contain sodium azide or other preservatives. |
|
|
|
|
home
